Armata Pharmaceuticals names David House CFO
ARMP•Armata promotes David House to chief financial officer
Armata Pharmaceuticals promoted David House to chief financial officer as it prepares to advance AP-SA02 into Phase 3.
House previously served as senior vice president, finance, and principal financial officer since August 2024.




